K. Chengappa

Relationship of birth cohort and early age at onset of illness in a bipolar disorder case registry.

D. Kupfer, E. Frank, P. Houck, 2003, The American journal of psychiatry.

The off-label use of clozapine in adolescents with bipolar disorder, intermittent explosive disorder, or posttraumatic stress disorder.

K N Roy Chengappa, R. Kant, Ravi Kant, 2004, Journal of child and adolescent psychopharmacology.

Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone

D. Kupfer, J. Calabrese, M. Tohen, 2004, British Journal of Psychiatry.

The prevalence of akathisia in patients receiving stable doses of clozapine.

R. Baker, N. Schooler, M. Shelton, 1994, The Journal of clinical psychiatry.

Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder: a randomized, placebo-controlled trial.

J. Hulihan, N. Rosenthal, J. Xiang, 2006, The Journal of clinical psychiatry.

Adjunctive Use of a Standardized Extract of Withania somnifera (Ashwagandha) to Treat Symptom Exacerbation in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study.

Jessica M. Gannon, Patricia J. Schlicht, K. Chengappa, 2018, The Journal of clinical psychiatry.